Veru (VERU) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Veru (NASDAQ:VERU) issued its earnings results on Thursday. The company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by ($0.05), MarketWatch Earnings reports. Veru had a negative return on equity of 52.81% and a negative net margin of 150.89%. The company had revenue of $5.20 million during the quarter, compared to analysts’ expectations of $7.25 million.

Shares of VERU opened at $1.35 on Friday. Veru has a one year low of $1.10 and a one year high of $2.37. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.01 and a quick ratio of 0.80.

Several brokerages have recently weighed in on VERU. HC Wainwright set a $5.00 target price on Veru and gave the stock a “buy” rating in a research report on Friday. Zacks Investment Research raised Veru from a “sell” rating to a “buy” rating and set a $1.50 target price for the company in a research report on Wednesday, October 17th. Finally, Maxim Group reaffirmed a “buy” rating and issued a $10.00 target price on shares of Veru in a research report on Monday, August 27th. Five research analysts have rated the stock with a buy rating, Veru has an average rating of “Buy” and a consensus price target of $5.50.



A number of institutional investors and hedge funds have recently modified their holdings of VERU. BlackRock Inc. boosted its holdings in Veru by 475.1% in the second quarter. BlackRock Inc. now owns 113,563 shares of the company’s stock valued at $229,000 after purchasing an additional 93,815 shares during the last quarter. AWM Investment Company Inc. boosted its holdings in Veru by 72.4% in the third quarter. AWM Investment Company Inc. now owns 1,000,000 shares of the company’s stock valued at $1,420,000 after purchasing an additional 420,000 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Veru by 328.8% in the third quarter. Dimensional Fund Advisors LP now owns 102,909 shares of the company’s stock valued at $146,000 after purchasing an additional 78,909 shares during the last quarter. Perceptive Advisors LLC purchased a new position in Veru in the third quarter valued at about $2,024,000. Finally, Hound Partners LLC purchased a new position in Veru in the third quarter valued at about $119,000. 9.73% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Veru (VERU) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS” was first reported by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://dakotafinancialnews.com/2018/12/15/veru-veru-releases-quarterly-earnings-results-misses-expectations-by-0-05-eps.html.

Veru Company Profile

Veru Inc operates as a urology and oncology biopharmaceutical company. The company operates through two segments, Commercial; and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation.

See Also: Different Types of Derivatives

Earnings History for Veru (NASDAQ:VERU)

Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply